Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings

Bibliographic Details
Main Authors: Lima, Viviane D, Hull, Mark, McVea, David, Chau, William, Harrigan, P Richard, Montaner, Julio SG
Format: Online
Language:English
Published: International AIDS Society 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976295/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976295/

Similar Items